
Iomeprol Injectable Solution
Form: Injectable Solution
Strength: 350 mg/mL and 400 mg/mL
Reference Brands: Iomeron(US & EU)
Category: Contrast Agent
Iomeprol injectable solution, marketed as Iomeron, is approved in the US by the FDA and in the EU via EMA for contrast-enhanced imaging procedures including CT angiography and vascular imaging. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality information to ensure safety and effectiveness, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe administration, and worldwide availability, supporting high-quality diagnostic imaging globally.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Sulfur Hexafluoride Microbubbles injection
Strength: 60.7mg
Form: injection
Reference Brands: SonoVue(EU)
View Details Get EnquiryBarium Sulfate Suspension
Strength: 30% w/v , 40% w/v
Form: Powder for oral suspension
Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)
View Details Get EnquiryGadoxetate Injectable Solution
Strength: 0.25 mmol/mL
Form: Injectable Solution
Reference Brands: Eovist(US)
View Details Get EnquiryGadofosveset Injectable solution
Strength: 0.03 mmol/kg
Form: Injectable Solution
Reference Brands: Ablivar(US & EU)
View Details Get Enquiry